Blog Layout

Study Finds Nearly Half of Adult Cancer Deaths in the US Could Be Prevented Through Lifestyle Changes

"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019"

American Cancer Society

In 2018, the authors reported estimates of the number and proportion of cancers attributable to potentially modifiable risk factors in 2014 in the United States. These data are useful for advocating for and informing cancer prevention and control. Herein, based on up-to-date relative risk and cancer occurrence data, the authors estimated the proportion and number of invasive cancer cases (excluding nonmelanoma skin cancers) and deaths, overall and for 30 cancer types among adults who were aged 30 years and older in 2019 in the United States, that were attributable to potentially modifiable risk factors. These included cigarette smoking; second-hand smoke; excess body weight; alcohol consumption; consumption of red and processed meat; low consumption of fruits and vegetables, dietary fiber, and dietary calcium; physical inactivity; ultraviolet radiation; and seven carcinogenic infections. Numbers of cancer cases and deaths were obtained from data sources with complete national coverage, risk factor prevalence estimates from nationally representative surveys, and associated relative risks of cancer from published large-scale pooled or meta-analyses. In 2019, an estimated 40.0% (713,340 of 1,781,649) of all incident cancers (excluding nonmelanoma skin cancers) and 44.0% (262,120 of 595,737) of all cancer deaths in adults aged 30 years and older in the United States were attributable to the evaluated risk factors. Cigarette smoking was the leading risk factor contributing to cancer cases and deaths overall (19.3% and 28.5%, respectively), followed by excess body weight (7.6% and 7.3%, respectively), and alcohol consumption (5.4% and 4.1%, respectively). For 19 of 30 evaluated cancer types, more than one half of the cancer cases and deaths were attributable to the potentially modifiable risk factors considered in this study. Lung cancer had the highest number of cancer cases (201,660) and deaths (122,740) attributable to evaluated risk factors, followed by female breast cancer (83,840 cases), skin melanoma (82,710), and colorectal cancer (78,440) for attributable cases and by colorectal (25,800 deaths), liver (14,720), and esophageal (13,600) cancer for attributable deaths. Large numbers of cancer cases and deaths in the United States are attributable to potentially modifiable risk factors, underscoring the potential to substantially reduce the cancer burden through broad and equitable implementation of preventive initiatives.


Link to Full Article:  https://acsjournals.onlinelibrary.wiley.com/doi/full/10.3322/caac.21858

Share this Article with others

By Sorena Nadaf February 13, 2025
January 2025 Newsletter: The Year of Artificial Intelligence Sorena Nadaf-Rahrov, MS, MMI, PhDc
By Sorena Nadaf February 5, 2025
A recent Lancet study demonstrated that AI implementation led to a 29% increase in cancer detection, with no increase in false positives and a reduced workload compared to radiologists without AI assistance. While emerging evidence supports AI’s potential to enhance cancer detection in mammography screening and reduce screen-reading workload, further research is needed to fully understand its clinical impact.
By Sorena Nadaf December 10, 2024
Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry
By Sorena Nadaf November 11, 2024
With heavy hearts, we remember and honor Brady Davis, whose sudden passing leaves an immense void. Brady was a devoted supporter and invaluable contributor to the Cancer Center Informatics Society, dedicating countless hours to advancing our mission and strengthening our community. His expertise, enthusiasm, and unwavering commitment shaped our initiatives and inspired everyone fortunate enough to work alongside him. Brady’s legacy will live on through the progress he championed and the connections he fostered. We extend our deepest sympathies to his family, friends, and all who knew him. He will be greatly missed. In honor of Brady’s legacy, Ci4CC will be forming a committee to explore meaningful ways to memorialize him within our society for years to come. We plan to announce the committee’s recommendations at our Spring Summit in San Diego, CA, on March 31, 2025. Please find his obituary here , and visit his memorial page on MyKeeper to leave a tribute. Support the Davis family in Brady’s memory via GoFundMe ---------- Cancer Center Informatics Society (Ci4CC) Sorena Nadaf-Rahrov & Warren Kibbe Co-Founders, Ci4CC
By Sorena Nadaf October 29, 2024
Nature Digital Medicine PRISM: Patient Records Interpretation for Semantic clinical trial Matching system using large language models
By Sorena Nadaf September 4, 2024
American Cancer Society and Color Health to Provide Free At-Home Colorectal Cancer Screening in Underserved Rural Communities
September 4, 2024
Leading Progress Against Cancer
August 24, 2024
By Drs Karen Knudsen & Othman Laraki.
By Sorena Nadaf July 18, 2024
Conversation with The Cancer Letter: NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready” - July 12, 2024
May 29, 2024
The UCSF Division of Clinical Informatics and Digital Transformation (DoC-IT) and UCSF Health have received a $5 million gift from Ken and Kathy Hao to develop a cutting-edge, real-time, continuous, and automated artificial intelligence (AI) monitoring platform for clinical care. The Impact Monitoring Platform for AI in Clinical Care (IMPACC) aims to bridge the gap between the rapid evolution of AI technologies used by clinicians and the essential need for robust, ongoing assessment of their efficacy, safety, and equity. Julia Adler-Milstein, PhD , chief of the UCSF Division of Clinical Informatics and Digital Transformation (DoC-IT), and Sara Murray, MD, MAS , chief health AI officer at UCSF Health, will lead the pioneering collaboration. “This philanthropic gift is transformative in many ways,” said Adler-Milstein. “It comes at a critical juncture as the healthcare industry more broadly integrates AI into clinical practice. Through IMPACC and this collaborative effort, we are poised to improve patient care at UCSF while advancing the science of how to assess AI tools in real-world use.” Currently, the healthcare field lacks established protocols for ongoing AI monitoring, leading to risks of adverse outcomes for patients and healthcare providers that go undetected. While assessments are conducted to determine the suitability of new AI technologies for safe integration into clinical environments before deployment, once they are deployed, health systems need a way to promptly identify any issues in their real-world performance. IMPACC will fill this urgent need by shifting from planned, periodic, manual monitoring of a focused set of measures to real-time, continuous, automated, and longitudinal monitoring across a broad measure set with specified criteria for escalation to human review and intervention.  Full Article: https://docit.ucsf.edu/news/ucsf-and-ucsf-health-receive-pivotal-donation-support-first-continuous-ai-monitoring-platform
Share by: